Log in

Tricida Stock Price, Forecast & Analysis (NASDAQ:TCDA)

$35.85
-0.87 (-2.37 %)
(As of 11/15/2019 05:50 AM ET)
Today's Range
$35.30
Now: $35.85
$37.30
50-Day Range
$29.58
MA: $34.73
$39.53
52-Week Range
$19.43
Now: $35.85
$42.80
Volume285,900 shs
Average Volume263,695 shs
Market Capitalization$1.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.85
Tricida, Inc, a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). It has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TCDA
CUSIPN/A
CIKN/A
Phone415-429-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$4.62 per share

Profitability

Net Income$-102,810,000.00

Miscellaneous

Employees76
Market Cap$1.77 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive TCDA News and Ratings via Email

Sign-up to receive the latest news and ratings for TCDA and its competitors with MarketBeat's FREE daily newsletter.


Tricida (NASDAQ:TCDA) Frequently Asked Questions

What is Tricida's stock symbol?

Tricida trades on the NASDAQ under the ticker symbol "TCDA."

How were Tricida's earnings last quarter?

Tricida Inc (NASDAQ:TCDA) released its quarterly earnings data on Thursday, August, 8th. The company reported ($0.75) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.87) by $0.12. View Tricida's Earnings History.

What price target have analysts set for TCDA?

3 analysts have issued twelve-month price objectives for Tricida's shares. Their forecasts range from $48.00 to $58.00. On average, they anticipate Tricida's stock price to reach $51.50 in the next twelve months. This suggests a possible upside of 43.7% from the stock's current price. View Analyst Price Targets for Tricida.

What is the consensus analysts' recommendation for Tricida?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tricida in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tricida.

Has Tricida been receiving favorable news coverage?

News articles about TCDA stock have been trending somewhat negative on Friday, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tricida earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Tricida.

Are investors shorting Tricida?

Tricida saw a increase in short interest in October. As of October 31st, there was short interest totalling 3,590,000 shares, an increase of 5.9% from the September 30th total of 3,390,000 shares. Based on an average trading volume of 199,400 shares, the short-interest ratio is currently 18.0 days. Approximately 10.4% of the shares of the stock are short sold. View Tricida's Current Options Chain.

Who are some of Tricida's key competitors?

What other stocks do shareholders of Tricida own?

Who are Tricida's key executives?

Tricida's management team includes the folowing people:
  • Dr. Gerrit Klaerner, Founder, Pres, CEO & Exec. Director (Age 48)
  • Mr. Geoffrey M. Parker, CFO & Sr. VP (Age 54)
  • Dr. Dawn Parsell Ph.D., Sr. VP of Clinical Devel. (Age 57)
  • Steffen Pietzke, VP of Fin. & Chief Accounting Officer
  • Dr. Wilhelm Stahl, CTO & Sr. VP (Age 59)

When did Tricida IPO?

(TCDA) raised $175 million in an IPO on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

Who are Tricida's major shareholders?

Tricida's stock is owned by many different of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (0.64%), California Public Employees Retirement System (0.09%), Rhumbline Advisers (0.06%), Nisa Investment Advisors LLC (0.01%), Tower Research Capital LLC TRC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%). Company insiders that own Tricida stock include Beek Jeroen B Van, Claire Lockey, Dawn Parsell Otto, Edward J Hejlek, Geoffrey M Parker, Gerrit Klaerner, Klaus R Dr Veitinger, Longitude Capital Partners Ii,, Orbimed Advisors Llc, Robert J Alpern, Sandra I Coufal, Steffen Pietzke and Wilhelm Stahl. View Institutional Ownership Trends for Tricida.

Which major investors are selling Tricida stock?

TCDA stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA and Rhumbline Advisers. Company insiders that have sold Tricida company stock in the last year include Claire Lockey, Dawn Parsell Otto, Gerrit Klaerner, Klaus R Dr Veitinger, Robert J Alpern, Sandra I Coufal and Wilhelm Stahl. View Insider Buying and Selling for Tricida.

Which major investors are buying Tricida stock?

TCDA stock was bought by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Nisa Investment Advisors LLC, Tower Research Capital LLC TRC and Zurcher Kantonalbank Zurich Cantonalbank. Company insiders that have bought Tricida stock in the last two years include Beek Jeroen B Van, Edward J Hejlek, Geoffrey M Parker, Longitude Capital Partners Ii,, Orbimed Advisors Llc, Sandra I Coufal and Steffen Pietzke. View Insider Buying and Selling for Tricida.

How do I buy shares of Tricida?

Shares of TCDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tricida's stock price today?

One share of TCDA stock can currently be purchased for approximately $35.85.

How big of a company is Tricida?

Tricida has a market capitalization of $1.77 billion. The company earns $-102,810,000.00 in net income (profit) each year or ($4.64) on an earnings per share basis. Tricida employs 76 workers across the globe.View Additional Information About Tricida.

What is Tricida's official website?

The official website for Tricida is http://www.tricida.com/.

How can I contact Tricida?

Tricida's mailing address is 7000 SHORELINE COURT SUITE 201, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-429-7800 or via email at [email protected]


MarketBeat Community Rating for Tricida (NASDAQ TCDA)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Tricida and other stocks. Vote "Outperform" if you believe TCDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TCDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel